Goldman Higher on Earnings; Apple Tariff Relieve; Pfizer Drug Pivot

Stock Movers

On this episode of Stock Movers:
- Goldman Sachs (GS) shares are higher after reporting earnings. The big bank approved a $40 billion share buyback program and its 1Q equities trading revenue beat estimates.
- Apple (AAPL) is also higher with news of tech tariff exemptions. Needham analyst Laura Martin is also reiterating her Apple Buy position in addition to the news, maintaining her $225 price target.
- Pfizer (PFE) is down today as it plans to abandon its obesity pill, danuglipron, due to a potentially drug-related liver injury in a clinical trial patient. The company will instead invest in earlier-stage obesity treatments, a setback in its efforts to compete with Novo Nordisk and Eli Lilly in the weight-loss market.
- Intel (INTC) is soaring this morning as many chip-exposed companies are rising on news of a pause in US tariffs on chips and tech. Intel is also nearing an agreement to sell a stake in its programmable chips unit, Altera, to Silver Lake Management.

See omnystudio.com/listener for privacy information.

2025-04-14 3 min Transcript

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

Open the Transcript tab to load the transcript.

Chapters

No chapters available.